CORRECT: Arcontech profit and sales fall; Kromek profit tops forecast
15th Sep 2026 15:56
(Corrects the financial 2026 gross margin figure for Fusion Antibodies PLC to 58.3%.) Read More
| Price | 6.70p on 16-09-2026 at 07:20:55 |
|---|---|
| Change | 0.00p 0% |
| Buy | 6.80p |
| Sell | 6.60p |
| Last Trade: | Buy 37,238.00 at 6.70p |
| Day's Volume: | 104,418 |
| Last Close: | 6.70p |
| Open: | 6.70p |
| ISIN: | GB00BD7V5D43 |
| Day's Range | 6.70p - 6.70p |
| 52wk Range: | 5.95p - 12.80p |
| Market Capitalisation: | £43.91m |
| VWAP: | 6.692243p |
| Shares in Issue: | 655.30m |
Sector: Medical Services
Listed In: FTSE AIM All-Share,
Kromek (KMK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 37,238 | 6.70p | Ordinary |
08:20:54 - 16-Sep-26 |
| Buy* | 14,858 | 6.73p | Ordinary |
08:03:40 - 16-Sep-26 |
| Sell* | 52,322 | 6.676p | Ordinary |
08:03:37 - 16-Sep-26 |
| Buy* | 5,000 | 6.70p | Ordinary |
16:39:25 - 15-Sep-26 |
| Buy* | 30,400 | 6.70p | Suspected BUY Trade |
16:35:20 - 15-Sep-26 |
| Unknown* | 500,000 | 6.625p | Ordinary |
16:33:21 - 15-Sep-26 |
| Sell* | 1,355 | 6.679p | Ordinary |
16:20:57 - 15-Sep-26 |
| Sell* | 44,782 | 6.679p | Ordinary |
16:16:11 - 15-Sep-26 |
| Buy* | 10,622 | 6.80p | Ordinary |
16:15:49 - 15-Sep-26 |
| Sell* | 45,004 | 6.675p | Ordinary |
16:15:33 - 15-Sep-26 |
Kromek (KMK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 15th Sep 2026 11:36 am | RNS | Director Share Purchase |
| 14th Sep 2026 12:38 pm | RNS | Director Share Purchase |
| 14th Sep 2026 7:00 am | RNS | Final Results |
| 6th Aug 2026 7:00 am | RNS | Delivery of Third Milestone and Grant of Options |
| 3rd Aug 2026 7:00 am | RNS | Director Share Purchase |
| 4th Jun 2026 7:00 am | RNS | Grant of Long-Term Incentives |
| 2nd Jun 2026 7:00 am | RNS-R | Launch of new interactive investor hub |
| 1st Jun 2026 7:00 am | RNS | PDMR/Director Shareholding, Issue of Equity & TVR |
| 12th May 2026 7:00 am | RNS | Full Year 2026 Trading Update |
| 30th Apr 2026 2:30 pm | RNS | Issue of Equity, TVR & Extension of Options |